Founded in 1993, BTL Industries is a privately owned developer and manufacturer of Physiotherapy, Cardiology, and Aesthetic Equipment. With direct offices in more than 85 countries covering 5 continents, BTL currently has over 3800 employees, 400 R&D engineers, and growing. Its primary segments include cardiology, such as holter monitoring and stress test systems, pneumology, physical therapy, and medical aesthetics. BTL’s medical aesthetic line includes non-invasive body shaping technologies for fat cell disruption and body sculpting, as well as advanced systems for skin tightening, cellulite treatment, hair removal and facial therapies. BTL makes its worldwide marketing efforts through direct sales subsidiaries located in over 70 countries on 5 continents, as well as through a network of independent distributors. The US sales are headquartered in Boston, Massachusetts. BTL has a world-class ISO 13485 certified quality system, and is GMP compliant. Many of its products bear CE mark, are US FDA cleared and Health Canada licensed.